产地 | 进口、国产 |
品牌 | 上海莼试 |
保存条件 | Store at -20 °C |
货号 | CS11031 |
应用范围 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS编号 | |
抗体名 | Anti-RAG2 |
克隆性 | |
靶点 | 详见说明书 |
适应物种 | 详见说明书 |
形态 | 详见说明书 |
宿主 | 详见说明书 |
亚型 | IgG |
标识物 | 详见说明书 |
浓度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human RMND1 |
中文名称 重组激活基因2蛋白抗体品牌
英文名称 Anti-RAG2
别 名 RAG 2; RAG-2; RAG2; RAG2_HUMAN; Recombination activating gene 2; V(D)J recombination activating protein 2; V(D)J recombination-activating protein 2.
产品属性:
重组激活基因2蛋白抗体品牌 浓 度 1mg/1ml
规 格 0.2ml/200μg
抗体来源 Rabbit
克隆类型 polyclonal
交叉反应 Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep
产品类型 一抗
研究领域 细胞生物 免疫学 表观遗传学
蛋白分子量 predicted molecular weight: 58kDa
性 状 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human RAG2
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
重组激活基因2蛋白抗体品牌 产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蜡切片需做抗原修复)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍 Catalytic component of the RAG complex, a multiprotein complex that mediates the DNA cleavage phase during V(D)J recombination. V(D)J recombination assembles a diverse repertoire of immunoglobulin and T-cell receptor genes in developing B and T lymphocytes through rearrangement of different V (variable), in some cases D (diversity), and J (joining) gene segments. In the RAG complex, RAG1 mediates the DNA-binding to the conserved recombination signal sequences (RSS) and catalyzes the DNA cleavage activities by introducing a double-strand break between the RSS and the adjacent coding segment. RAG2 is not a catalytic component but is required for all known catalytic activities. DNA cleavage occurs in 2 steps: a first nick is introduced in the top strand immediately upstream of the heptamer, generating a 3'-hydroxyl group that can attack the phosphodiester bond on the opposite strand in a direct transesterification reaction, thereby creating 4 DNA ends: 2 hairpin coding ends and 2 blunt, 5'-phosphorylated ends. The chromatin structure plays an essential role in the V(D)J recombination reactions and the presence of histone H3 trimethylated at 'Lys-4' (H3K4me3) stimulates both the nicking and haipinning steps. The RAG complex also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B lymphocytes. The introduction of DNA breaks by the RAG complex on one immunoglobulin allele induces ATM-dependent repositioning of the other allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. In addition to its endonuclease activity, RAG1 also acts as a E3 ubiquitin-protein ligase that mediates monoubiquitination of histone H3. Histone H3 monoubiquitination is required for the joining step of V(D)J recombination. Mediates polyubiquitination of KPNA1.
Function : Core component of the RAG complex, a multiprotein complex that mediates the DNA cleavage phase during V(D)J recombination. V(D)J recombination assembles a diverse repertoire of immunoglobulin and T-cell receptor genes in developing B and T-lymphocytes through rearrangement of different V (variable), in some cases D (diversity), and J (joining) gene segments. DNA cleavage by the RAG complex occurs in 2 steps: a first nick is introduced in the top strand immediately upstream of the heptamer, generating a 3'-hydroxyl group that can attack the phosphodiester bond on the opposite strand in a direct transesterification reaction, thereby creating 4 DNA ends: 2 hairpin coding ends and 2 blunt, 5'-phosphorylated ends. The chromatin structure plays an essential role in the V(D)J recombination reactions and the presence of histone H3 trimethylated at 'Lys-4' (H3K4me3) stimulates both the nicking and haipinning steps. The RAG complex also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. The introduction of DNA breaks by the RAG complex on one immunoglobulin allele induces ATM-dependent repositioning of the other allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. In the RAG complex, RAG2 is not the catalytic component but is required for all known catalytic activities mediated by RAG1. It probably acts as a sensor of chromatin state that recruits the RAG complex to H3K4me3.
Subunit : Component of the RAG complex composed of core components RAG1 and RAG2, and associated component HMGB1 or HMGB2.
Subcellular Location : Nucleus.
DISEASE : Defects in RAG2 are a cause of combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650]. CHIDG is an immunodeficiency disease with granulomas in the skin, mucous membranes, and internal organs. Other characteristics include hypogammaglobulinemia, a diminished number of T and B-cells, and sparse thymic tissue on ultrasonography.
Defects in RAG2 are a cause of severe combined
immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive (T(-)B(-)NK(+) SCID) [MIM:601457]. A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.
Defects in RAG2 are a cause of Omenn syndrome (OS) [MIM:603554]. OS is a severe immunodeficiency characterized by the presence of activated, anergic, oligoclonal T-cells, hypereosinophilia, and high IgE levels.
Similarity : Belongs to the RAG2 family.
Contains 1 PHD-type zinc finger.
Database links : UniProtKB/Swiss-Prot: P55895.1
实验流程:
全、新、优、品、好四大特点:
重组激活基因2蛋白抗体品牌 全:公司提供上万种产品,涵盖了生物试剂,elisa试剂盒,标准品,培养基,原装耗材,抗体、培养基、ATCC细胞等,基本上各种科研所需产品在我司都能找到。
新:产品更新速度较快,基本上每周都有新产品出现。
优:产品质量好,投诉比较少。
好:我公司具有优质的技术团队,产品一旦售出,实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。
技术外包服务:
★重组激活基因2蛋白抗体品牌 分子生物学:质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学:基因合成、引物合成、基因测序、载体构建等
★蛋白工程:原核、哺乳动物蛋白表达系统等
★病毒包装:腺病毒、慢病毒等
★抗体工程:磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★细胞工程:细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。
正在热销的相关产品:
MAPK4(Mitogen-activated protein kinase 4) 原活化蛋白激酶4抗原Multi-class antibodies规格: 0.5mg
轴蛋白1Axin protein 1抗体 Anti-Axin1 0.1ml
Rhesus antibody Rh phospho-EGFR (Tyr1068) 磷酸化表皮生长因子受体抗体 规格 0.1ml
B27添加剂 (原装) 10ml Gibco
ZNF750 英文名称: 锌指蛋白750抗体 0.2ml
DTNBP1 英文名称: 易感基因抗体 0.1ml
轴蛋白1Axin protein 1抗体 Anti-Axin1 0.1ml
EphA1 R(Ephrin A1 Receptor) EphA1-R受体抗原Multi-class antibodies规格: 0.5mg
ATP酶通道蛋白抗体 Anti-ATP1b2/Na+K+ ATPase 0.1ml
Rhesus antibody Rh Phospho-EGFR (Tyr1138) 磷酸化表皮生长因子受体抗体 规格 0.1ml
DMEM/F12(1:1)培养液 250ml 国产
ZNF672 英文名称: 锌指蛋白672抗体 0.2ml
DISC1 (CT) 英文名称: DISC1 C端抗体 0.2ml
ATP酶通道蛋白抗体 Anti-ATP1b2/Na+K+ ATPase 0.1ml
ZEB1 英文名称: 负调控因子白细胞介素2抗体 0.2ml
DR1 protein 英文名称: 转录下调蛋白1抗体 0.2ml
衔接因子蛋白含pH域磷酸酪氨酸结合域和亮氨酸拉链基元1抗体 Anti-APPL1 0.1ml
Anti-CEA/Gold 胶体金离子标记鼠抗人癌胚抗原单克隆抗体(包被)IgGMulti-class antibodies规格: 0.2ml
Rhesus antibody Rh Phospho-eNOS (Thr113) 磷酸化合成酶3抗体(内皮型) 规格 0.1ml
E2F2 转录因子E2F-2抗原Multi-class antibodies规格: 0.5mg
TNFSF12 Protein Rat 重组大鼠 TNFSF12 蛋白 (Fc 标签)
DLD-1 人结直肠腺癌上皮细胞
CTSD Others Human 人 Cathepsin D / CTSD 人细胞裂解液 (阳性对照)
CMVECs微内皮细胞 CMVECs micro vascular endothelial cells DMEM+10%FBS
人导管癌细胞;ZR-75-1
人小梁网细胞(HTMC)(5×105) 3T3-L1, 小鼠前脂肪细胞 Mouse
CL-0435SF126(人细胞)5×106cells/瓶×2
HA Others H12N1 甲型 H12N1 (A/mallard duck/Alberta/342/1983) 血凝素 (Hemagglutinin / HA) 人细胞裂解液 (阳性对照)
大鼠视网膜神经节细胞完全培养基 100mL
HL-7702人正常肝细胞 HL-7702 human normal liver cell 1640+10% FBS
IL1RN Protein Rat 重组大鼠 IL-1RA / IL1RN 蛋白 (Fc 标签)
NCI-H596(人肺腺鳞癌细胞) 5×106cells/瓶×2 cv-1(非洲绿猴肾细胞)
重组激活基因2蛋白抗体品牌 TNFSF12 Protein Rat 重组大鼠 TNFSF12 蛋白 (Fc 标签)
DLD-1 人结直肠腺癌上皮细胞
CTSD Others Human 人 Cathepsin D / CTSD 人细胞裂解液 (阳性对照)
CMVECs微内皮细胞 CMVECs micro vascular endothelial cells DMEM+10%FBS
人导管癌细胞;ZR-75-1
人小梁网细胞(HTMC)(5×105) 3T3-L1, 小鼠前脂肪细胞 Mouse